Indirect comparisons suggest zilucoplan may improve certain MG severity scores more than eculizumab, ravulizumab, or IVIG.
Only 1 in 3 patients with hereditary ATTR-PN has their diagnosis confirmed by ancillary testing, according to a recent study.
Patients with mantle cell lymphoma (MCL) aged 75 years or older had lower CAR-T use and higher mortality before CAR-T than ...
Persistent SIRS may indicate increased risk for organ failure, infections, and mortality in acute pancreatitis, a major FCS ...
Sonrotoclax is effective and well tolerated in patients with relapsed/refractory MCL based on results of a meta-analysis of ...
TP53 alterations were consistently associated with inferior survival across treatment approaches in mantle cell lymphoma (MCL ...
A network meta-analysis of phase 3 trials found that adding a BTKi consistently improves disease control in patients with MCL ...
In Patients With Mitochondrial Disease, Pancreatitis Can Present Early, Without Typical Risk Factors
Pancreatitis in patients with mitochondrial disease often presents in childhood, recurs, and occurs without conventional risk ...
Rates of meningococcal infection have stayed low and stable among US patients with MG or NMOSD treated with eculizumab or ...
No significant differences in the rates of autism or attention deficit hyperactivity disorder were observed between genetic ...
A mother whose son has TK2d says we need to keep collecting data as patients grow to reap the full potential of newly ...
An MCN of 54-67 and a UK-GR cytogenetic profile identified subgroups of children with high-hyperdiploid ALL and favorable outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results